FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / ip-side-letter-execution.docx
ip-side-letter-execution.docx · 1018-00004

Parties

General Counsel Penterra Pharmaceuticals Corp
Clinical Affairs Penterra Pharmaceuticals Corp

Dates

June 28, 2023
January 15, 2023

Amounts

$80,000,000
$1,500,000

Obligations

(c) "Confidential Information" has the meaning ascribed to such term in the MCTA and Exhibit F thereto (Confidentiality and Data Protection Provisions), and shall be subject to a confidentiality term of ten (10) years from the date of disclosure
Net Sales shall be calculated in accordance with United States Generally Accepted Accounting Principles ("GAAP"), consistently applied
2 — Interpretation Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to such terms in the MCTA
1 — Retention of Pre-Existing IP Each Party shall retain all right, title, and interest in and to its Pre-Existing IP
Nothing in this Side Letter, the MCTA, or any exhibit, schedule, or amendment thereto shall be construed as transferring, assigning, or conveying ownership of Pre-Existing IP from one Party to the other, whether by implication, estoppel, or otherwise
1 — Exclusive Sponsor Ownership Penterra shall retain exclusive ownership of all Study Data generated in connection with the CLARION trial, consistent with the terms of the MCTA and Exhibit G thereto